Structured authoring is an approach that has eluded life sciences, limiting firms’ ability to transform routine regulatory processes. But this could all change, writes Romuald Braun.
Romuald Braun
Advertisement
Articles by Romuald Braun
Advertisement
Latest Updated Articles
Why It’s Time to Get Smarter about Content Management and Document ProductionPublished: June 1st 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
2
Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan
3
Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026
4
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences
5